So they approved Keytrudas and what is better there as opposed to DcVaxL Science?? In fact all CIs trigger deadly autoimmune disorders. Ask Longfellow.
Your prediction is absolutely wrong and doesn’t make any sense.
We will be close to $25M in revenue from Specials program this year. The first half of the year will be slow, but as the word spreads about our phenomenal results, publication as well as return to normalcy in a milder COVID world, we will see a nice ramp up in the second half of this year.
Market Data 
Markets 
AI
